Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APPsw mice

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 8, 2001, Pages 778-785

  Mori, Takashi ^a   Paris, Daniel ^a   Town, Terrence ^a   Rojiani, Amyn M ^a   Sparks, D Larry ^b   Delledonne, Anthony ^a   Crawford, Fiona ^a   Abdullah, Laila I ^a   Humphrey, James A ^d   Dickson, Dennis W ^c   Mullan, Michael J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d NONE

Author keywords

Alzheimer disease; Cholesterol; Senile plaque; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLESTEROL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FLUOROMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE; STAINING; TECHNIQUE; TRANSGENIC MOUSE;

EID: 0034928074     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.8.778     Document Type: Article

References (28)

1. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
2. Apolipoprotein E: Polymorphism and Alzheimer's disease
3. Apolipoprotein E alleles as risk factors in Alzheimer's disease
4. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
5. Coronary artery disease, hypertension, apoE, and cholesterol: A link to Alzheimer's disease?
6. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol
7. Intraneuronal beta-amyloid immunoreactivity in the CNS
8. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
9. The role of cholesterol in the biosynthesis of beta-amyloid
10. Regulation of amyloid precursor protein cleavage
11. Functional rafts in cell membranes
12. Lipid binding to amyloid beta-peptide aggregates: Preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids
13. Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice
14. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: A commentary
15. Neuropathological staging of Alzheimer-related changes
16. Apolipoprotein E genotyping by one-stage PCR
17. Cholesterol distribution in rat liver and brain mitochondria as determined by stopped-flow kinetics with filipin
18. Differential accumulation of cholesterol in Golgi compartments of normal and Niemann-Pick type C fibroblasts incubated with LDL: A cytochemical freeze-fracture study
19. Fluorometric method for the enzymatic determination of cholesterol
20. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease
21. Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease
22. Comparative analysis of Aβ chemical structure and amyloid plaque morphology of transgenic mice and Alzheimer disease brains
23. Association of polyene antibiotics with sterol-free lipid membranes: I. Hydrophobic binding of filipin to dimyristoylphosphatidylcholine bilayers
24. Biochemistry of lipids, lipoproteins, and membranes
25. Free cholesterol-induced cytotoxicity. A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions
26. Cholesterol domains in biological membranes
27. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging
28. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4